dc.contributor.author |
Kopp, Hans-Georg |
|
dc.contributor.author |
Kimmich, Martin |
|
dc.date.accessioned |
2021-07-27T10:57:51Z |
|
dc.date.available |
2021-07-27T10:57:51Z |
|
dc.date.issued |
2021 |
|
dc.identifier.issn |
1758-8359 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/117335 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Sage Publications Ltd |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1177/1758835921996506 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20210512015105_00581 |
|
utue.personen.roh |
Metzenmacher, Martin |
|
utue.personen.roh |
Kopp, Hans-Georg |
|
utue.personen.roh |
Griesinger, Frank |
|
utue.personen.roh |
Reinmuth, Niels |
|
utue.personen.roh |
Sebastian, Martin |
|
utue.personen.roh |
Serke, Monika |
|
utue.personen.roh |
Waller, Cornelius Florian |
|
utue.personen.roh |
Thomas, Michael |
|
utue.personen.roh |
Eggert, Jochen |
|
utue.personen.roh |
Schmid-Bindert, Gerald |
|
utue.personen.roh |
Hoiczyk, Mathias |
|
utue.personen.roh |
Christoph, Daniel Christian |
|
utue.personen.roh |
Kimmich, Martin |
|
utue.personen.roh |
Deuss, Burkhard |
|
utue.personen.roh |
Seifert, Stephanie |
|
utue.personen.roh |
Held, Swantje |
|
utue.personen.roh |
Schuler, Martin |
|
utue.personen.roh |
Herold, Thomas |
|
utue.personen.roh |
Breitenbuecher, Frank |
|
utue.personen.roh |
Eberhardt, Wilfried Ernst Erich |
|
dcterms.isPartOf.ZSTitelID |
Therapeutic Advances in Medical Oncology |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 1758835921996506 |
de_DE |
dcterms.isPartOf.ZS-Volume |
13 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |